Greenwich LifeSciences Inc Gains 26.99%
Mon, Jan 24, 2022 at 05:30 PM
Greenwich LifeSciences Inc (GLSI:NASDAQ) shot up at $20.7, representing a gain of 27%. On Fri, Jan 21, 2022, GLSI:NASDAQ hit a New 2-Week Low of $16.3. The stock got featured on our News Catalysts scanner on Mon, Jan 24, 2022 at 06:45 AM in the 'INSIDER' category. From Mon, Jan 10, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days
About Greenwich LifeSciences Inc (GLSI:NASDAQ)
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Top 10 Gainers:
- Exterran Corporation (EXTN:NYSE), 59.67%
- ShiftPixy, Inc. (PIXY:NASDAQ), 38.71%
- Kohl's Corporation (KSS:NYSE), 36.02%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 26.99%
- Sweetgreen Inc. Class A (SG:NYSE), 23.34%
- Gelesis Holdings Inc. (GLS:NYSE), 22.37%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 21.25%
- Atlas Technical Consultants, Inc. (ATCX:NASDAQ), 20.13%
- Immunome Inc. (IMNM:NASDAQ), 19.46%
- Akouos Inc. (AKUS:NASDAQ), 19.14%